Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: Primary care

What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)

Aryeh Fischer, MD, and Jeff Swigris, DO, MS  |  December 1, 2012

Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
 

Filed under:Clinical Criteria/GuidelinesConditionsResearch RheumRheumatoid ArthritisSjögren’s Disease Tagged with:DiagnosisILDimagingInterstitial Lung Diseasepatient careResearchRheumatoid arthritisrheumatologistSjogren'sTreatment

CORRONA Team Provides Data-Based Tool to Address Rheumatology’s Questions

Gretchen Henkel  |  December 1, 2012

The Consortium of Rheumatology Researchers of North America (CORRONA) patient registry collects a host of treatment and disease indicators for a variety of rheumatic diseases at every physician visit

Filed under:ConditionsGout and Crystalline ArthritisInformation TechnologyPractice SupportProfilesPsoriatic ArthritisQuality Assurance/ImprovementResearch RheumRheumatoid ArthritisTechnologyTechnology Tagged with:Goutpatient carepatient registryProfilePsoriatic ArthritisResearchRheumatoid arthritisrheumatologistTechnologyTreatment

Introducing RhMSUS—Musculoskeletal Ultrasound Certification in Rheumatology

Staff  |  November 15, 2012

The American College of Rheumatology (ACR) has launched the long-awaited certification program for musculoskeletal (MSUS) ultrasound in rheumatology

Filed under:Career DevelopmentCertificationEducation & TrainingFrom the CollegeMeeting ReportsProfessional Topics Tagged with:AC&RACR NewsACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)CertificationEducationimagingMSUSrheumatologistTrainingUltrasound

President’s Perspective: Big Questions, Bent Forks, and New Names

James O'Dell, MD  |  November 1, 2012

The ACR year in review

Filed under:Information TechnologyLegislation & AdvocacyPresident's PerspectiveProfessional TopicsTechnologyTechnology Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)imagingLegislationMSUSREF NewsrheumatologistRheumPACSimple TasksTechnologyUltrasound

Rheumatology Drug Updates: Apremilast, Golimumab, and More

Michele B. Kaufman, PharmD, BCGP  |  November 1, 2012

Information on new approvals and medication safety rheumatologists need to know

Filed under:AnalgesicsAxial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesPsoriatic Arthritis Tagged with:Ankylosing SpondylitisBiologicsBiosimilarsdrugFDAinfliximabJAK inhibitorsjanus kinaseMethotrexatePipelinePolymyalgia RheumaticaprednisonePsoriatic ArthritisRheumatoid arthritisSafetyTofacitinib

The Future is Here: The Role of Nurse Practitioners in Rheumatology

Ann Kepler  |  November 1, 2012

Nurse practitioners’ specialized knowledge and skills help to create an interlocking network of rheumatology patients and medical professionals

Filed under:Career DevelopmentEducation & TrainingPractice SupportProfessional TopicsWorkforce Tagged with:axial spondyloarthritis (SpA)nurse practitionerOsteoarthritispatient carePractice ManagementRheumatoid arthritisSclerodermaSystemic lupus erythematosusTraining

Why We Are Advocates

James R. O’Dell, MD  |  September 5, 2012

Rheumatology advocacy efforts are paying off in 2012.

Filed under:Legislation & AdvocacyPresident's PerspectiveProfessional TopicsResearch Rheum Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)LegislationResearchrheumatologistSGRSimple Tasks

High-Impact Rheumatology Practice Redesign

J. Timothy Harrington, MD, and Eric D. Newman, MD  |  August 8, 2012

It’s time to start adapting your practice to changes in the healthcare system.

Filed under:EMRsInformation TechnologyPractice SupportQuality Assurance/ImprovementTechnologyTechnologyWorkforce Tagged with:Association of Rheumatology Professionals (ARP)Educationelectronic health recordPractice ManagementRheumatoid arthritisrheumatologistTechnology

Volunteering Is Informative—and Fun

Alfred E. Denio, MD  |  June 10, 2012

A former ACR board of directors member chronicles his interpretation of the activities of the board over the past three years, highlighting issues that are likely on the minds of ACR members.

Filed under:EMRsLegislation & AdvocacyProfessional TopicsTechnology Tagged with:AC&RACR Board of DirectorsAdvocacyAmerican College of Rheumatology (ACR)electronic health recordimagingrheumatologistTechnologyUltrasoundVolunteer

Systemic Juvenile Idiopathic Arthritis

Rayfel Schneider, MBBCh, and Ronald M. Laxer, MDCM  |  May 9, 2012

Changing treatment paradigms in the biologic era

Filed under:Clinical Criteria/GuidelinesConditionsRheumatoid Arthritis Tagged with:AC&RAmerican College of Rheumatology (ACR)anti-inflammatorydrugJIAJuvenile idiopathic arthritismacrophage activation syndromeMethotrexatepatient carePediatricsrheumatologistSteroidstocilizumabTreatment

  • « Previous Page
  • 1
  • …
  • 122
  • 123
  • 124
  • 125
  • 126
  • …
  • 136
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences